Facet Biotech Chief Business Officer “Terminated”

January 7, 2009 |

1 min read

January 6, 2009 - San Francisco Business Times - Redwood City’s Facet Biotech Corp. — recently spun off from PDL BioPharma Inc. — will part with its chief business officer Friday.

People

MORE ON THIS TOPIC

IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch

IPO tracker

Avalyn plots IPO to push inhaled pulmonary fibrosis pipeline through clinic

April 9, 2026

·

7 min read

·

Tristan Manalac

Japanese-style New Year's card template for the year of the snake1 (horizontal type) (without greeting text) Snake, Mt. Fuji, sunrise, clouds

Funding

Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors

April 9, 2026

·

2 min read

·

Tristan Manalac

Stylish gold office chair standing on black award podium over black background. Concept of success, being number one in business and victory celebration. 3d rendering

C-suite

Novavax Shareholder Vows To Fight CEO Pay Package, End ‘Dogmatic Leadership’

April 8, 2026

·

3 min read

·

Annalee Armstrong

Large sharp meat cleaver sticking out of a rustic wood cutting board on a grey background. 3d render.

Mergers & acquisitions

Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data

April 8, 2026

·

3 min read

·

Tristan Manalac